Lineage Cell Therapeutics, Inc(NYSE MKT:LCTX) 
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapies for the treatment of degenerative diseases in the United States and internationally. The company's lead product candidates include OpRegen, a retinal pigment epithelium cell r...
Website: http://www.lineagecell.com
Full Time Employees: 50
CEO: Brian M. Culley
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.42
H 0.44
L 0.40
C 0.43
V 1,998,432
10EMA 0.43
20EMA 0.43
60EMA 0.43
120EMA 0.43
250EMA 0.43